February 2016 Newsletter

February 18, 2016:

2015 in Review: Acquisitions Continue at Record-Setting Pace in Ophthalmic Market

Actavis’ $70.5 billion purchase of Allergan set new mark for price.

February 18, 2016:

Myopia Epidemic, Zika-Related Eye Issues Among Major Topics Discussed at 2016 WOC

A session on LASIK looked at the satisfaction rate of doctors who had the procedure at the Cleveland Clinic.

February 18, 2016:

Michael Ball to Lead Alcon in Major Restructuring

Novartis said it will invest $200 million in its eye care division.

February 18, 2016:

Alcon Acquires Transcend Medical

The privately held company is developing the CyPass Micro-Stent to treat glaucoma.

February 18, 2016:

Glaucoma 360 New Horizons Forum Discusses Successful Formula for Developing Treatments

FDA’s Malvina Eydelman said future approval process will include parameter for evaluating patient perspective.

February 18, 2016:

Quarter of Surgeons at Glaucoma 360 Offer iStent Procedure, Survey Results Show

Market Scope partnered with the Glaucoma Research Foundation to develop a custom survey for the meeting, which was held in January in San Francisco.

February 18, 2016:

Study: Statins May Ease Dry Form of AMD

In an early stage clinical trial, the treatment cleared away fatty deposits behind the retina, leading to slight visual improvement in 10 of 23 patients.

February 18, 2016:

Schiller Tells Lawmakers Valeant is Changing; Committee Threatens More Oversight of Drug Prices

Hearing looked at recent spikes in pricing that made huge profits for drugmakers.

February 18, 2016:

Valeant’s Pearson Says He’s Recovering after ‘Complications’

The longtime CEO and chairman of the multinational drug company has been on medical leave since Dec. 28

February 18, 2016:

Allergan Eyes Waco Plant for Possible Expansion

Facility currently manufactures Restasis and Latisse.

February 18, 2016:

Pfizer Names Executive Leadership Following Closing of Allergan Deal

Bill Meury will oversee Allergan’s ophthalmology and aesthetics businesses.

February 18, 2016:

World’s Largest Chain of Eye Hospitals in Receivership in India

Newly opened hospitals failed to make enough money to pay debts incurred to open them.

February 18, 2016:

2015 in Review: Ophthalmic Firms Raise $847 Million for Product Development

Total was about half the record set in 2014.

February 18, 2016:

2015 in Review: IOL Manufacturers Make Considerable Regulatory Progress

The first automated capsulotomy device received CE marking.

February 18, 2016:

2015 in Review: Regulatory Approvals Limited to Familiar Ophthalmic Drugs

The FDA backed new formulations of mature drugs, new indications, and generics.

February 18, 2016:

AIOS: India to Lift Ban on Avastin for Ophthalmic Use

Roche will reintroduce a security code to its vials, society says.

February 18, 2016:

Shire Resubmits NDA for Lifitegrast as Dry Eye Treatment

Shire’s application now includes data from five randomized controlled clinical trials.

February 18, 2016:

Market Report: Expanding Needs in Retinal Device Market will Drive Revenue Growth

The market is expected to grow to $2.7 billion by 2021, partly due to the impact of newer retinal implant devices.

February 18, 2016:

Market Report: Demand for Disposables will Fuel Growth in Ophthalmic Surgical Instruments

The global market for surgical instruments is expected to exceed $1.14 billion in 2016.

February 18, 2016:

Second Sight Offers Option Arrangement for Existing Shareholders

Two large shareholders have committed a combined $12.8 million toward the investment round.

February 18, 2016:

Sunlight, Genes Play Integral Role in Myopia, Researcher Says

In a study of Western Australian twins, high vitamin D levels were associated with lower myopia.

February 18, 2016:

Data Snapshot: 37 Percent of Glaucoma Specialists Plan to Buy Equipment in Next 12 Months

The question on business plans is new to the survey. Fourth-quarter results were published Feb. 15.

February 18, 2016:

Study: OCT Offers Window to MS Progression

After four years, a comparison of the long-term MRI and OCT results showed the rate of tissue thinning seen on OCT mirrored overall brain degeneration.

February 18, 2016:

GoodRx, Blink Health are Expedia for Prescription Drugs

The two online companies are trying to change the way Americans buy drugs by quoting the lowest prices for generic prescriptions to allow comparison shopping.

February 18, 2016:

Encore Vision Completes Enrollment in Study of Eye Drops to Treat Presbyopia

The Fort Worth, Texas, company plans to release results in Q2-2016.

February 18, 2016:

Henry Edelhauser, Leader in Translational Vision Research, Dies at 78

He was honored in 2012 by the Association for Research in Vision and Ophthalmology’s Foundation for Eye Research for his body of work.

February 18, 2016:

February 2016 News Briefs

Social media